financetom
Business
financetom
/
Business
/
Democratic lawmakers seek review of DOJ cases involving Pam Bondi's brother
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Democratic lawmakers seek review of DOJ cases involving Pam Bondi's brother
Mar 11, 2026 12:19 PM

March 11 (Reuters) - Two Democratic lawmakers on

Wednesday asked the U.S. Department of Justice's watchdog to

review whether U.S. Attorney General Pam Bondi has properly

recused herself from cases involving clients of her brother Brad

Bondi, a partner at a prominent law firm.

U.S. Sen. Adam Schiff and Rep. Dave Min asked DOJ Deputy

Inspector General William Blier to review whether Pam Bondi has

"adequately recused" herself from cases involving her brother,

and whether the department implemented the right safeguards.

They said they never received a response to a December 16

letter asking the attorney general and her deputy Todd

Blanche what steps were being taken in cases "in which Mr.

Bondi's involvement likely poses a conflict of interest for the

attorney general."

Brad Bondi and his law firm Paul Hastings did not

immediately respond to requests for comment. Bondi co-chairs the

firm's investigations and white-collar defense practice.

Spokespeople for the Justice Department and the DOJ's

inspector general's office did not immediately respond to

requests for comment.

Schiff and Min said in their letter to Blier that Bondi in

January posted on LinkedIn several victories he and his team won

in 2025, including on behalf of Nikola founder Trevor Milton,

who was convicted of fraud in 2022 and then pardoned by

President Donald Trump last year.

Other defendants Bondi represented had their criminal cases

delayed unnecessarily or dropped, Schiff and Min said.

"Given the troubling pattern at the department of repeated

interventions or dismissals in cases involving Mr. Bondi, we are

concerned that DOJ officials, including the attorney general,

may have failed to ensure the independence of internal

accountability mechanisms," Schiff and Min wrote.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Google DeepMind Announces Protocols to Identify Harmful AI Capabilities
Update: Google DeepMind Announces Protocols to Identify Harmful AI Capabilities
May 17, 2024
11:54 AM EDT, 05/17/2024 (MT Newswires) -- (Updates with additional details throughout.) Alphabet's (GOOG, GOOGL) Google DeepMind introduced its Frontier Safety Framework on Friday, a set of protocols to proactively identify future AI capabilities that could cause severe harm and mitigate them. While AI technology is set to revolutionize the way we solve critical global problems, from climate change to...
National Bank Says Loblaw 2024 Supplier Summit
National Bank Says Loblaw 2024 Supplier Summit "Reinforces Key Themes"
May 17, 2024
11:52 AM EDT, 05/17/2024 (MT Newswires) -- On May 16, Loblaw ( LBLCF ) hosted a supplier summit in Toronto, featuring presentations from executive members. Loblaw ( LBLCF ) participants included Galen Weston, Chairman; Per Bank, President and CEO; Richard Dufresne, CFO, Major topics included accelerating square footage growth (in discount and Shoppers Drug Mart), ongoing cost reduction efforts (supply...
What's Going On With Crown Electrokinetics Stock?
What's Going On With Crown Electrokinetics Stock?
May 17, 2024
Crown Electrokinetics Corp. ( CRKN ) shares are trading higher Friday as the stock receives attention from traders on social media. Here's a look at what's going on.  The Details: Retail traders appear to be moving to smaller-cap stocks, including Faraday Future Intelligent Electric Inc. ( FFIE ) and Crown Electrokinetics ( CRKN ), as the rally in GameStop and...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports
May 17, 2024
May 17 (Reuters) - Moderna ( MRNA ) has won a case at the European Patent Office in its dispute with Pfizer ( PFE ) and BioNTech over its COVID-19 vaccine, the Financial Times reported on Friday. Moderna ( MRNA ) did not immediately respond to a Reuters request for comment. (Reporting by Sriparna Roy in Bengaluru; Editing by Anil...
Copyright 2023-2026 - www.financetom.com All Rights Reserved